High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone

Author:

Milosevic Michael F.12,Pintilie Melania3,Hedley David W.4567,Bristow Robert G.1246,Wouters Bradly G.246,Oza Amit M.57,Laframboise Stephane89,Hill Richard P.246,Fyles Anthony W.12

Affiliation:

1. Radiation Medicine Program, Princess Margaret Cancer Center, University Health Network; Toronto Canada

2. Department of Radiation Oncology; University of Toronto; Toronto Canada

3. Department of Clinical Study Coordination and Biostatistics; Princess Margaret Cancer Center, University Health Network; Toronto Canada

4. Department of Advanced Molecular Oncology; Princess Margaret Cancer Center, University Health Network; Toronto Canada

5. Department of Medical Oncology; Princess Margaret Cancer Center, University Health Network; Toronto Canada

6. Department of Medical Biophysics; University of Toronto; Toronto Canada

7. Department of Medicine; University of Toronto; Toronto Canada

8. Department of Gynecologic Oncology; Princess Margaret Cancer Center, University Health Network; Toronto Canada

9. Department of Obstetrics/Gynecology; University of Toronto; Toronto Canada

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Ferlay J Shin HR Bray F Globocan 2008: Cancer Incidence and Mortality Worldwide 2010

2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials;Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration;J Clin Oncol,2008

3. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer;Fyles;Radiother Oncol,2006

4. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy;Yeo;Clin Cancer Res,2009

5. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix;Hockel;Cancer Res,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3